EGFR and non-small cell lung carcinoma: This showed that the pre-radiotherapy SII, NLR, PLR, and LMR levels were the key prognostic factors of metastatic NSCLC with EGFR mutations; the low NLR, PLR, and LMR levels were associated with a better prognosis for patients.